Quick Links Investor Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases March 20, 2026 Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting March 6, 2026 Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC) February 17, 2026 Incyte to Present at Upcoming Investor Conferences All press releases Latest Events Mar 11 2026 Mar 11 2026 Barclays 28th Annual Global Healthcare Conference Click here for Webcast Mar 10 2026 Mar 10 2026 Leerink Partners Global Healthcare Conference Click here for Webcast Mar 2 2026 Mar 2 2026 TD Cowen 46th Annual Health Care Conference Click here for Webcast All events
